Cinobufocini inhibits NF-κB and COX-2 activation induced by TNF-α in lung adenocarcinoma cells

Oncology Reports

Volumn 27, Issue 5, 2012, Pages 1619-1624

  Wang, Ju Yong ^a   Chen, Ling ^b   Zheng, Zhan ^a   Wang, Qing ^a   Guo, Jing ^a   Xu, Ling ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Cinobufocini; Cyclooxygenase 2; Lung cancer; Nuclear factor B

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; CINOBUFOCINI; CYCLOOXYGENASE 2; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; LUCIFERASE; MESSENGER RNA; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATIONAL STUDY; CYTOKINE PRODUCTION; DRUG STRUCTURE; ENZYME INHIBITION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ADENOCARCINOMA; AMPHIBIAN VENOMS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLOOXYGENASE 2; ENZYME ACTIVATION; GENE EXPRESSION; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; LUNG NEOPLASMS; MEDICINE, CHINESE TRADITIONAL; NF-KAPPA B; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84863273874     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1647     Document Type: Article

References (32)

1. Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, Zhu J and Johnson D: Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Eng J Med 346: 92-98, 2002. (Pubitemid 34438899)
2. Krenn L and Kopp B: Bufadienolides from animal and plant sources. Phytochemistry 48: 1-29, 1998. (Pubitemid 28242374)
3. Cao YH and Luo HS: Clinical observation of cinobufacini injection used to treat advanced primary liver cancer. Zhong Guo Yi Xue Wen Zhai Lao Nian Yi Xue 1: 8-10, 2007 (In Chinese).
4. Wang Y, Li JM, Yang CM, Zhang L and Shen ZX: Study on apoptosis of NB4 cells induced by cinobufagin and its mechanism. Tumor 6: 534-537, 2005.
5. Yang G, Yu F, Fu H, Lu F, Huang B, Bai L, Zhao Z, Yao L and Lu Z: Identification of the distinct promoters for the two transcripts of apoptosis related protein 3 and their transcriptional regulation by NFAT and NFkappaB. Mol Cell Biochem 302: 187-194, 2007. (Pubitemid 47202334)
6. Cao Y and Prescott SM: Many actions of cyclooxygenase-2 in cellular dynamics and in cancer. J Cell Physiol 190: 279-286, 2002. (Pubitemid 34111968)
7. Chen W, Bai L, Wang X, Xu S, Belinsky SA and Lin Y: Acquired activation of the AKT/cyclooxygenase-2/Mcl-1 pathway renders lung cancer cells resistant to apoptosis. Mol Pharmacol 77: 416-423, 2010.
8. Oh GS, Pae HO, Choi BM, Seo EA, Kim DH, Shin MK, Kim JD, Kim JB and Chung HT: 20(S)-Protopanaxatriol, one of ginsenoside metabolites, inhibits inducible nitric oxide synthase and cyclooxygenase-2 expressions through inactivation of nuclear factor-kappaB in RAW 264.7 macrophages stimulated with lipopolysaccharide. Cancer Lett 205: 23-29, 2004. (Pubitemid 38230135)
9. Sugimori K, Matsui K, Motomura H, Tokoro T, Wang J, Higa S, Kimura T and Kitajima I: BMP-2 prevents apoptosis of the N1511 chondrocytic cell line through PI3K/Akt-mediated NF-kappaB activation. J Bone Miner Metab 23: 411-419, 2005. (Pubitemid 41571106)
10. Huang TT, Kudo N, Yoshida M and Miyamoto S: A nuclear export signal in the N-terminal regulatory domain of IkappaBalpha controls cytoplasmic localization of inactive NF-kappaB/IkappaBalpha complexes. Proc Natl Acad Sci USA 97: 1014-1019, 2000. (Pubitemid 30080804)
11. Pikarsky E: NF-kappaB function as a tumor promoter in inflammation-associated cancer. Nature 431: 461-466, 2004.
12. Al-Hanbali M, Ali D, Bustami M, Abdei-Malek S, Al-Hanbali R, Alhaussainy T, Qadan F and Matalka KZ: Epicatechin suppresses IL-6, IL-8 and enhances IL-10 production with NF-kappaB nuclear translocation in whole blood stimulated system. Neuro Endocrinol Lett 30: 131-138, 2009.
13. Luo JL, Kamata H and Karin M: IKK/NF-κB signaling: balancing life and death-a new approach to cancer therapy. J Clin Invest 115: 2625-2632, 2005. (Pubitemid 41434385)
14. Coussens LM and Werb Z: Inflammation and cancer. Nature 420: 860-867, 2002. (Pubitemid 36019639)
15. He W, Liu Q, Wang L, Chen W, Li N and Cao X: TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance. Mol Immunol 44: 2850-2859, 2007. (Pubitemid 46412506)
16. Tang X, Liu D, Shishodia S, Ozburn N, Behrens C, Lee JJ, Hong WK, Aggarwal BB and Wistuba II: Nuclear factor-kappaB (NF-kappaB) is frequently expressed in lung cancer and preneoplastic lesions. Cancer 107: 2637-2646, 2006. (Pubitemid 44845619)
17. Mantovani A, Allavena P, Sica A and Balkwill F: Cancer-related inflammation. Nature 454: 436-444, 2008.
18. Wang JY, Jin Y, Xu ZY, Zheng Z and Wan S: Involvement of caspase-3 activity and survivin down-regulation in cinobufocini-induced apoptosis in A 549 cells. Exp Biol Med (Maywood) 234: 566-572, 2009.
19. Li Q and Verma IM: NF-kappaB regulation in the immune system. Nat Rev Immunol 2: 725-734, 2002.
20. Visscher DW, Pankratz VS, Santisteban M, Reynolds C, Ristimaki A, Vierkant RA, Lingle WL, Frost MH and Hartmann LC: Association between cyclooxygenase-2 expression in atypical hyperplasia and risk of breast cancer. J Natl Cancer Inst 100: 421-427, 2008. (Pubitemid 351480513)
21. Malkinson A M, Radcliffe RA and Bauer AK: Quantitative trait locus mapping of susceptibilities to butylated hydroxytoluene-induced lung tumor promotion and pulmonary inflammation in CXB mice. Carcinogenesis 23: 411-417, 2002. (Pubitemid 34257620)
22. Dranoff G: Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer 4: 11-22, 2004.
23. Blackwell TS and Christman JW: The role of nuclear factor-κB in cytokine gene regulation. Am J Respir Cell Mol Biol 17: 3-9, 1997. (Pubitemid 127500814)
24. Yu YY, Li Q and Zhu ZG: NF-kappaB as a molecular target in adjuvant therapy of gastrointestinal carcinomas. Eur J Surg Oncol 31: 386-392, 2005. (Pubitemid 40521305)
25. Esfandi F, Mohammadzadeh Ghobadloo S and Basati G: Interleukin-6 level in patients with colorectal cancer. Cancer Lett 244: 76-78, 2006. (Pubitemid 44485868)
26. Salgado R, Junius S, Benoy I, Van Dam P, Vermeulen P, Van Mark E, Huget P and Dirix LY: Circulating interleukin-6 predicts survival in patients with metastatic breast cancer. Int J Cancer 103: 642-646, 2003. (Pubitemid 36091468)
27. Malicki S, Winiarski M, Matlok M, Kostarczyk W, Guzdek A and Konturek PC: IL-6 and IL-8 responses of colorectal cancer in vivo and in vitro cancer cells subjected to simvastatin. J Physiol Pharmacol 60: 141-146, 2009.
28. Kim MY, Oskarsson T, Acharyya S, Nguyen DX, Zhang XH, Norton L and Massague J: Tumor self-seeding by circulating cancer cells. Cell 139: 1315-1326, 2009.
29. Su YH, Huang XQ, Zhang DZ, Zhang YN, Xie JM and Ling CQ: HPLC separation and determination of bufadienolide in cinobufacini injection. Chinese Traditional Patent Medicine 25: 25-27, 2003 (In Chinese).
30. Qi F, Inagaki Y, Gao B, Cui X, Xu H, Kokudo N, Li A and Tang W: Bufalin and cinobufagin induce apoptosis of human hepatocellular carcinoma cells via Fas- and mitochondria-mediated pathways. Cancer Sci 102: 951-958, 2011.
31. Yu CH, Kan SF, Pu HF, Jea Chien E and Wang PS: Apoptotic signaling in bufalin-and cinobufagin-treated androgen-dependent and-independent human prostate cancer cells. Cancer Sci 99: 2467-2476, 2008.
32. Jiang Y, Zhang Y, Luan J, Duan H, Zhang F, Yagasaki K and Zhang G: Effects of bufalin on the porliferation of huamn lung cancer cells and its molecular mechanisms of action. Cytochnology 62: 573-583, 2010.